Rationale: The withdrawal of humans from high doses of psychostimulant drugs can result in a transient syndrome which appears isomorphic to endogenous depression. One of the more prominent symptoms is a loss of hedonic capacity; in animals, the anhedonia associated with amphetamine withdrawal has been measured objectively by decrements in responding for intracranial self-stimulation (ICSS).

Objective: To date, the effects of amphetamine withdrawal on ICSS responding have been reversed by different antidepressant drugs. In the present study, we sought to reverse withdrawal-induced anhedonia by administration of repeated electroconvulsive shocks (ECS).

Methods: Rats with electrodes in the lateral hypothalamus were trained on an ascending-series current intensity ICSS paradigm until stable levels of responding were attained. Half of the animals were then administered a 4-day escalating dose schedule of d-amphetamine, and tests for ICSS responding started 12 h after the final injection. During withdrawal, all animals received daily treatment with either ECS or sham-ECS.

Results: Amphetamine withdrawal was associated with reduced ICSS responding; animals treated with ECS exhibited a facilitated recovery compared to sham-ECS treated animals, and returned to control levels of ICSS responding 24 h earlier.

Conclusions: ECS was able to mitigate the anhedonic effects of d-amphetamine withdrawal, and provides additional support for the use of psychostimulant withdrawal as a model of depression.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s002130100906DOI Listing

Publication Analysis

Top Keywords

icss responding
16
amphetamine withdrawal
12
repeated electroconvulsive
8
effects d-amphetamine
8
withdrawal
8
d-amphetamine withdrawal
8
responding
6
animals
5
icss
5
electroconvulsive shock
4

Similar Publications

This study examined the influence of socio-economic factors on the adoption of improved cookstoves (ICSs) and identified barriers to their dissemination in Wereta district, Amhara, Ethiopia. A structured cross-sectional approach was employed, surveying 308 households through questionnaires and interviews. Key socio-economic factors such as income level, family size, education, and age were found to significantly affect ICS adoption (p < 0.

View Article and Find Full Text PDF

Introduction: Treatment options for chronic obstructive pulmonary disease (COPD) are numerous but adherence remains a key challenge. We performed a discrete choice experiment (DCE) of patients' preferences in accessing care for the management of COPD. The aim of this study was to understand patients' preferences for modes of accessing care for the management of COPD.

View Article and Find Full Text PDF

Background: Most smokers attempting to quit will quickly relapse to tobacco use even when treated with the most efficacious smoking cessation agents currently available. This highlights the need to develop effective new smoking cessation medications. Evidence suggests that positive allosteric modulators (PAM) and other enhancers of nicotinic acetylcholine receptor (nAChR) signaling could have therapeutic utility as smoking cessation agents.

View Article and Find Full Text PDF

Multivalent Pt/TiCTx Nanocomposite-Based Immunochromatographic Sensor for Colorimetric/Temperature/Pressure Trimodal Detection.

Anal Chem

September 2024

Key Laboratory of Luminescence Analysis and Molecular Sensing (Ministry of Education), College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.

Multimodal immunochromatographic sensors (ICSs) have acquired extensive attention since they not only provide reliable results by comparing the different output signals but also flexibly respond to various application environments. Herein, an ICS with triple signal outputs including colorimetry, temperature, and pressure was developed for sensitive detection of chlorothalonil. The multivalent Pt/TiCTx nanoparticles as signal tags were facilely synthesized by loading PtNPs onto single-layer TiCTx nanosheets with high surface area.

View Article and Find Full Text PDF

A Roadmap for Using Causal Inference and Machine Learning to Personalize Asthma Medication Selection.

JMIR Med Inform

April 2024

Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, United States.

Inhaled corticosteroid (ICS) is a mainstay treatment for controlling asthma and preventing exacerbations in patients with persistent asthma. Many types of ICS drugs are used, either alone or in combination with other controller medications. Despite the widespread use of ICSs, asthma control remains suboptimal in many people with asthma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!